April 30, 2025
Ted Jackson/AP

8 possible indicators of how RFK Jr.’s HHS will handle vaccine policy

Kennedy's early moves as HHS chief suggest he may intervene on vaccine policy, with Novavax, mRNA shots, and pediatric Covid immunizations.

By Helen Branswell


STAT+ | Collins and fellow GOP senators speak out in opposition to Trump’s cuts to biomedical research

Trump's canceled NIH grants and HHS layoffs threaten U.S. biomedical leadership, Collins says, as she calls for funding to be restored.

By John Wilkerson


Will the FDA approve the first new drug to help people quit smoking in 20 years?

Firm working on first new stop smoking drug in nearly 20 years will seek FDA approval in June for cytisinicline, promises fewer side effects than Chantix.

By Sarah Todd



JEAN-FRANCOIS MONIER/AFP/Getty Images

STAT+ | NIH plans to reduce animal testing in federally funded research

"With this initiative, NIH is ushering in a new era of innovation,” said the agency's director, Jay Bhattacharya.

By Ed Silverman


STAT+ | Health systems in limbo as HHS stays quiet on nondiscrimination rules for AI, algorithms

By May 1, federally-funded health systems were to show that technology they use don't discriminate against patients based on protected traits.

By Katie Palmer


STAT+ | Opinion: A dangerous new push to ban embryonic stem cell research funding is gaining momentum

Such a ban would mean less hope for cell therapy development for patients facing many kinds of medical conditions.

By Paul Knoepfler


Opinion: The end of the medical school cadaver lab?

Said one medical student whose school is doing away with cadavers: 'The biggest lesson I took from cadaver lab was just being in the presence of death.'

By Torie Bosch


STAT+ | Despite Kennedy’s stated support, funding for Women’s Health Initiative remains in limbo

Funding for a landmark health study, the Women's Health Initiative, was set to end then reportedly saved, but researchers still await confirmation.

By Elizabeth Cooney


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.